PRYP5

Across TCGA pan-cancer cohorts, PRYP5 RNA is linked to patient survival in 4 of 34 cancer types, making it the most broadly survival-associated PRYP5 data layer.

The strongest signal is observed in kidney chromophobe (KICH), where higher PRYP5 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated PRYP5 expression acts as an unfavorable survival marker.

KICH, LUAD, and CESC are the cancer types where PRYP5 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KICH	DFS	Tertile	All	0.025	0.904	<.001	108	view →
LUAD	OS	Tertile	All	0.194	0.685	.004	72	view →
CESC	OS	Tertile	All	0.013	0.875	<.001	36	view →
ESCA	OS	Tertile	All	0.211	0.876	.028	18	view →

Pink = unfavorable, green = favorable. Showing the 4 strongest of 4 lineages.

PRYP5–KICH (DFS)

Open the KICH breakdown →